Beta-blocker Stratification using MRI to assess portal pressure (B-SMaRT)

Provide proof of concept that quantitative haemodynamic MRI markers can stratify the efficacy of carvedilol to lower clinically significant portal hypertension in patients with cirrhosis.

Webpage:
https://www.healthdatagateway.org/dataset/e09e1735-a54a-49cd-81f1-484040d76a5a

Licence:
Name: HDR UK Innovation Gateway Access
URL: https://www.hdruk.ac.uk/infrastructure/gateway/terms-and-conditions/

Tags:

cirrhosis portal hypertension varices mri magnetic resonance imaging beta-blockers beta blockers

More to explore:

1/20



Need help integrating and/or managing biomedical data?